Results 1 to 10 of about 73,286 (248)
Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis [PDF]
Vulvovaginal candidiasis is a common infection associated most often with the overgrowth of the fungal species Candida albicans . Although most women will have at least one episode of vulvovaginal candidiasis in their lifetime, some will experience ...
Mark Martens
exaly +4 more sources
Risk factors for recurrent vulvovaginal candidiasis [PDF]
Background/Aim. Recurrent vulvovaginal candidiasis is relatively frequent condition, and may have serious health consequences, like chronic vulvovaginal pain syndrome. The aim of our study was to determine possible risk factors for recurrent vulvovaginal
Janković Slobodan +13 more
doaj +4 more sources
Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods
Vulvovaginal candidiasis (VVC) is a common condition associated with discomfort in affected women. Due to the presence of different forms of the disease, diverse treatment regimens are developed; the newest ones include oteseconazole and ibrexafungerp ...
Krzysztof Kułak +2 more
exaly +2 more sources
Vulvovaginal candidiasis (VVC) is experienced by an estimated 75% of women at least once in their lifetime and is recurrent, defined as three or more infections per year (RVVC) in 5–9%.
N. Phillips +2 more
exaly +2 more sources
A Comprehensive Overview of <i>Candida albicans</i> as the Leading Pathogen in Vulvovaginal Candidiasis. [PDF]
Candida albicans is the primary etiological agent of vulvovaginal candidiasis (VVC), a widespread fungal infection affecting millions of women worldwide. Although often self-limiting, VVC can become recurrent or severe, significantly impacting quality of
Srb N +6 more
europepmc +2 more sources
Epidemiological data on women suffering from vulvovaginal candidiasis and its recurrence are outdated and vague. The aim of this study was to identify the prevalence of women diagnosed with vulvovaginal candidiasis, as well as the epidemiological profile
Encarnación Martínez-García +6 more
doaj +2 more sources
Fluconazole-resistant vulvovaginal candidiasis in reproductive-age women: a study from Himalayan country [PDF]
Background Vulvovaginal candidiasis is the second most common fungal infections among reproductive-age women. These conditions are commonly treated with the azole derivatives administered locally or systemically, most commonly fluconazole (FCZ).
Deepshikha Yadav +6 more
doaj +2 more sources
Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
Recurrent vulvovaginal candidiasis is a common disorder which causes significant morbidity among women worldwide, and treatment options are limited.
Leah M. Grant MD, Robert Orenstein DO
doaj +1 more source
HIGHLIGHTS 1. Hormonal changes during pregnancy lead to the presence of vulvovaginal candidiasis. 2. Increased incidence of vulvovaginal candidiasis in different pregnancy trimesters were analyzed. 3.
Regina Martina Cilik +2 more
doaj +1 more source
Frequency and Etiology of Vulvovaginal Candidiasis in Women Referred to a Gynecological Center in Babol, lran [PDF]
Background Vulvovaginal candidiasis is the most common fungal disease in sexually active women of which Candida albicans is the primary etiologic agent. Materials and methods This cross-sectional study was performed to determine the etiologic agents of
Seddigheh Esmaeilzadeh +2 more
doaj +1 more source

